For 2020, the International Psoriasis Council is pleased to announce the availability of five year-long fellowships through the IPC International Fellowship Program.
Meet the 2018 IPC International Fellows.
Meet the 2019 IPC International Fellows.
The International Fellowship Program aims to increase the number and ability of clinicians and scientists focused on researching and treating psoriasis. Beginning in January 2020, fellows will be matched with, and observe, IPC Board Members and Councilors in their clinics and laboratories to get real world practice in researching, diagnosing, developing treatment plans and monitoring treatment regiments for psoriasis patients. In addition, the program will provide an opportunity for IPC Fellows to develop on-going relationships with key opinion leaders by participating in IPC programs and activities throughout the one-year Fellowship period.
Fellowships are available to early career dermatologists in training or junior faculty who have completed their training within the last five years and are interested in improving their abilities to treat and manage psoriasis patients, gain exposure to international key opinion leaders and develop leadership skills among peers.
Complete the online application, uploading the following in PDF format:
Application for the 2020 Fellowships is now closed. Please check back in September 2020 for information about 2021 Fellowships.
Sites are available in Latin America, North America, Europe and Asia. IPC will provide the final site list to awarded fellows who will then select their top three choices. Final matches will be made by the Steering Committee, comprised of IPC Board Members and Councilors.
Learn more about the program
For questions about the IPC International Fellowship Program, please send an email to Fellowship@psoriasiscouncil.org.
Latest news Commentary: The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologicsMay 28, 2020Searching for signals of increased risk of infection in specific subgroups is vitally important, especially when confronted with a severe threat to health, like the worldwide spread of the SARS-CoV-2 virus. Stories from the Field: COVID-19 and Psoriatic ArthritisMay 27, 2020US-based rheumatologist and IPC Councilor Arthur Kavanaugh, MD, discusses his plans to continue offering telemedicine appointments to patients after the pandemic. "Telemedicine is a new skill set that [we] providers need to learn," says Dr. Kavanaugh in this week's Stories from the Field video. Translations NOW AVAILABLE: January 2020 Psoriasis Review NewsletterMay 26, 2020 Stories from the Field: Impact of COVID-19 restrictions on psoriasis patients in EgyptMay 20, 2020Due to COVID-19 restrictions, patients in Egypt with severe psoriasis are not getting timely access to biologic treatment. IPC Board Member Mahira Hamdy El Sayed, MSc, MD, discusses the potential fallout for Egyptians with psoriasis, post-COVID-19. More News